About (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid
(3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid (PubChem CID 68826070) has the molecular formula C24H38BrN5O6
and a molecular weight of 572.50 g/mol. Its IUPAC name is (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid.
Molecular Properties
| Compound Name | (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid |
| PubChem CID | 68826070 |
| Molecular Formula | C24H38BrN5O6 |
| Molecular Weight | 572.50 g/mol |
| Exact Mass | 571.20 |
| IUPAC Name | (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid |
| SMILES | COCCCCn1cc(Br)nc1C(=O)N(CC(C)C)[C@H]1C[C@@H](C(=O)N2CCOCC2)CN(C(=O)O)C1 |
| InChI | InChI=1S/C24H38BrN5O6/c1-17(2)13-30(23(32)21-26-20(25)16-28(21)6-4-5-9-35-3)19-12-18(14-29(15-19)24(33)34)22(31)27-7-10-36-11-8-27/h16-19H,4-15H2,1-3H3,(H,33,34)/t18-,19+/m1/s1 |
| InChIKey | PGICTDPRKDRYNC-MOPGFXCFSA-N |
| XLogP | 2.40 |
| TPSA | 117.44 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 572.50 |
| LogP ≤ 5 | 2.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid?
The IUPAC name of (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid (CID 68826070) is (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid.
What is the SMILES notation for (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid?
The canonical SMILES for (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid is COCCCCn1cc(Br)nc1C(=O)N(CC(C)C)[C@H]1C[C@@H](C(=O)N2CCOCC2)CN(C(=O)O)C1.
What is the InChIKey of (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid?
The InChIKey is PGICTDPRKDRYNC-MOPGFXCFSA-N. The full InChI is InChI=1S/C24H38BrN5O6/c1-17(2)13-30(23(32)21-26-20(25)16-28(21)6-4-5-9-35-3)19-12-18(14-29(15-19)24(33)34)22(31)27-7-10-36-11-8-27/h16-19H,4-15H2,1-3H3,(H,33,34)/t18-,19+/m1/s1.
What are the key properties of (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid?
(3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid has a molecular weight of 572.50 g/mol, XLogP of 2.40, 10 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,5R)-3-[[4-bromo-1-(4-methoxybutyl)imidazole-2-carbonyl]-(2-methylpropyl)amino]-5-(morpholine-4-carbonyl)piperidine-1-carboxylic acid is sourced from PubChem (CID 68826070), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).